Literature DB >> 23702119

Current management of sickle cell disease in pregnancy.

Biree Andemariam1, Sabrina L Browning.   

Abstract

Life expectancy in sickle cell disease (SCD) has increased substantially and thus women with SCD are almost universally reaching child-bearing age. Studies on potential complications during pregnancy have generated mixed data; however, it is generally accepted that women with SCD are at higher risk for adverse pregnancy outcomes and maternal mortality. It is therefore critical that their care be provided by a team that includes a hematologist and a maternal-fetal medicine specialist. Despite the published risks, women with SCD are capable of successful pregnancy outcomes with proper education and well-coordinated multidisciplinary care. Further investigation is needed to standardize management.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23702119     DOI: 10.1016/j.cll.2013.03.023

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.

Authors:  Iain Willits; Helen Cole; Roseanne Jones; Kimberley Carter; Mick Arber; Michelle Jenks; Joyce Craig; Andrew Sims
Journal:  Appl Health Econ Health Policy       Date:  2017-08       Impact factor: 2.561

2.  Evaluation of Stillbirth Among Pregnant People With Sickle Cell Trait.

Authors:  Silvia P Canelón; Samantha Butts; Mary Regina Boland
Journal:  JAMA Netw Open       Date:  2021-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.